FDA announces flurry of emergency authorizations for COVID-19 products

2016 09 02 09 36 05 93 Fda Logo V2 400

The U.S. Food and Drug Administration (FDA) announced a flurry of emergency use authorizations (EUAs) for COVID-19 products, including reverse transcription polymerase chain reaction (RT-PCR) tests, ahead of the July Fourth holiday.

Cleared July 2

Cleared July 1

Cleared June 30

Cleared June 29

Page 1 of 7
Next Page